| Literature DB >> 31807557 |
Yingfei Lu1, Yu Zhou1,2, Rong Ju2, Jianquan Chen1,2.
Abstract
Organ transplantation is the most promising curation for end-stage organ disease. However, the donor organ shortage has become a global problem that has limited the development of organ transplantation. Human-animal chimeras provide the ability to produce human organs in other species using autologous stem cells [e.g., induced pluripotent stem cells (iPSCs) or adult stem cells], which would be patient-specific and immune-matched for transplantation. Due to the potential application prospect of interspecies chimeras in basic and translational research, this technology has attracted much interest. This review focuses primarily on technological advances, including options of donor stem cell types and gene editing in donor cells and host animals, in addition to perspectives on human-animal chimeras in clinical and basic research. 2019 Annals of Translational Medicine. All rights reserved.Entities:
Keywords: Autologous stem cells; embryo complementation; gene editing; human-animal chimeras; organ transplantation
Year: 2019 PMID: 31807557 PMCID: PMC6861770 DOI: 10.21037/atm.2019.10.13
Source DB: PubMed Journal: Ann Transl Med ISSN: 2305-5839